| Literature DB >> 31720908 |
M Alwahid1, S R Knight1, H Wadhawan1, K L Campbell1, D Ziyaie1, S M P Koch2.
Abstract
BACKGROUND: Rectal prolapse is a disease presentation with a prevalence of about 1%, mainly affecting older women. It usually presents with symptoms of rectal mass, rectal bleeding, fecal incontinence or constipation, with patients frequently feeling socially isolated as a result. Perineal rectosigmoidectomy is associated with lesser morbidity and mortality than the abdominal procedure, but with a much higher recurrence rate. Therefore, this technique is mainly suitable for the frail elderly patient. Specific outcomes in an elderly population have been described in only a few studies. We evaluated the morbidity, mortality, recurrence rate and functional results after this procedure related to age.Entities:
Keywords: Age; Altemeier; Perineal rectosigmoidectomy; Rectal prolapse
Mesh:
Year: 2019 PMID: 31720908 PMCID: PMC6872601 DOI: 10.1007/s10151-019-02100-z
Source DB: PubMed Journal: Tech Coloproctol ISSN: 1123-6337 Impact factor: 3.781
Patient characteristics
| Whole cohort | Age < 80 years | Age ≥ 80 years | ||
|---|---|---|---|---|
| Number of patients | 45 | 22 | 23 | na |
| Sex (M:F) | 2:43 | 1:21 | 1:22 | 1.000 |
| Age (years) | 82.0 (70.5–86.5) | 71.0 (63.0–75.0) | 86.0 (85.0–91.0) | na |
| ASA class | 3.0 | 3.0 | 3.0 | 0.802 |
| BMI kg/m2 | 23.0 (20.5–25.0) | 23.5 (20.5–24.5) | 23.0 (21.5–25.0) | |
| Operation time (mins) | 105.0 (75.0–120.5) | 110.0 (75.0–130.0) | 97.0 (71.3–120.3) | 0.753 |
| Length of specimen (cm) | 8.9 (6.9–13.6) | 9.5 (7.0–14.3) | 8.0 (6.5–13.8) | 0.773 |
| Length of stay (days) | 6.0 (4.5–11.5) | 5 (5.0–13.5) | 6.5 (3.5–11.0) | 0.775 |
| Follow-up (months) | 20.0 (8.5–45.5) | 25 (8.5–46.5) | 17.5 (8.5–31.0) | 0.391 |
Values stated are median and IQR in parentheses
p value in bold means a significant difference
na not applicable, ASA American Society of Anesthesiologists, BMI body mass index
Symptoms at presentation
| (a) Whole cohort | |||
|---|---|---|---|
| Preoperative symptoms | Postoperative symptoms | ||
| Rectal mass | 27 (60.0) | 4 (8.9) | |
| Painful defecation | 8 (17.8) | 2 (4.4) | 0.080 |
| Fecal incontinence | 21 (46.7) | 7 (15.6) | |
| Rectal bleeding | 9 (20.0) | 3 (6.7) | 0.118 |
| Constipation | 12 (26.7) | 2 (4.4) | |
p values in bold mean a significant difference
Postoperative complications following perineal rectosigmoidectomy
| Number of patients (%) | |||
|---|---|---|---|
| Whole cohort | Age < 80 years | Age ≥ 80 years | |
| General complications | |||
| Pneumonia | 2 (4.4) | 0 | 2 (9.0) |
| Transient ischemic attack | 1 (2.2) | 1 (4.5) | 0 |
| Incarcerated femoral hernia | 1 (2.2) | 0 | 1 (4.5) |
| Local complications | |||
| Anastomotic leak | 3 (6.7) | 2 (9.1) | 1 (4.5) |
| Pararectal abscess | 1 (2.2) | 0 | 1 (4.5) |
| Hemorrhage | 2 (4.4) | 2 (9.1) | 0 |
| Postoperative diarrhea | 2 (4.4) | 2 (9.1) | 0 |
| Rectal ulcer | 2 (4.4) | 2 (9.1) | 0 |
| Total complications | 14 (31.1) | 9 (42.9) | 5 (22.7) |
| Patients requiring reoperation | 3 (6.7) | 2 (9.1) | 1 (4.5) |
| Death | 0 | 0 | 0 |
Outcomes after perineal rectosigmoidectomy
| Number of patients (%) | |||
|---|---|---|---|
| Whole cohort | Age < 80 years | Age ≥ 80 years | |
| 30-day mortality | 0 | 0 | 0 |
| Reoperation | 3 (6.7) | 2 (9.1) | 1 (4.5) |
| Recurrence | 6 (13.3) | 4 (18.2) | 2 (9.0) |
| Second procedure | 4 (8.9) | 3 (13.6) | 1 (4.5) |
Literature overview for perineal rectosigmoidectomy
| Author | Study design | Age (years) | Mortality (%) | Morbidity (%) | Leak rate (%) | Incontinence | Recurrence (%) | Levatorplasty | Follow-up (months) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Preop | Postop | ||||||||||
| Altemeier et al. [ | 106 | Retrospective | 62.2b | 0 | 24.5 | 2.8 | NR | NR | 2.8 | + | 228b |
| Watts et al. [ | 33 | Retrospective | NR | 0 | NR | NR | NR | NR | 0 | NR | 23b |
| Williams et al. [ | 114 | Retrospective | 78a | 0 | 12 | 0.9 | 59 | 32 | 10 | +- | 12a |
| Johansen et al. [ | 20 | Prospective | 82b | 5 | NR | NR | NR | NR | 0 | + | 26b |
| Deen et al. [ | 10 | Retrospective | NR | 0 | NR | NR | NR | 20 | 10 | + | 18b |
| Ramanujam, et al. [ | 72 | NR | NR | 0 | NR | NR | NR | 66.7i | 6 | + | 120b |
| Agachan et al. [ | 32 | Retrospective | 75b | NR | 1 | 3.3 | NR | NR | 13 | NR | 30b |
| Kim et al. [ | 183 | Retrospective | 64a | NR | 14 | NR | NR | NR | 16 | NR | 47b |
| Zbar et al. [ | 80 | Retrospective | 69b | 0 | 2 | 2 | 5 | 0 | 4 | some | 22a |
| Habr-Gama et al. [ | 44 | Retrospective | 76b | 0 | 9 | NR | NR | 14 | 7.1 | + | 49b |
| Hammond et al. [ | 48 | Retrospective | 60.8 | 0 | NR | NR | NR | NR | 17 | – | 39b |
| Glasgow et al. [ | 103 | Retrospective | 75a | 0.9 | 8.5 | 4 | 75.5 | 41.5 | 8.5 | 68-86% | 21a 36b |
| Kim et al. [ | 38 | Prospective | 75a | 2.6 | 18.4 | 0 | 72 | 72 | 2.6 | 12/38 | 24a |
| Cirocco [ | 103 | Retrospective | 69b | 0 | 14 | 0 | 47 | 7 | 0 | + | 43b |
| Ris et al. [ | 60 | Prospective | 77 | 1.6 | 11.6 | 1.7 | NR | 62i | 14 | 21/60 | 48b |
| Mik et al. [ | 45 | Prospective | 67 | 0 | 19.1 | 8.9 | NR | NR | 14.8 | 18/45 | 32b |
| Current study | 45 | Retrospective | 82a78b | 0 | 31.1 | 6.7 | 46.7 | 15.6 | 13 | NR | 20b |
NR not recorded, i improvement
aMedian
bMean